Andromeda Capital’s Medtronic MDT Stock Holding History

Andromeda Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-37,985	Closed	-$2.35M	–	159
2014 Q3	$2.35M	Buy	+37,985	New	+$2.42M	0.14%	144

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Andromeda Capital's MDT Position: Q4 2014 in Review

Andromeda Capital sold out of Medtronic (MDT) in Q4 2014, closing a stake of 37,985 shares — an estimated $2.35M sold.

Andromeda Capital first reported a position in MDT in Q3 2014 and held it in 1 quarter. The position peaked at $2.35M in Q3 2014. 1,154 funds tracked by Wall St. Rank hold MDT as of Q4 2014.

Andromeda Capital reported no remaining Medtronic position as of Q4 2014 after selling out during the quarter.
Andromeda Capital sold 37,985 Medtronic shares in Q4 2014, an estimated $2.35M.
Andromeda Capital first reported a position in Medtronic in Q3 2014 and held it in 1 quarter.
Andromeda Capital's Medtronic position peaked at $2.35M in Q3 2014.
1,154 funds tracked by Wall St. Rank held Medtronic as of Q4 2014.

Based on Andromeda Capital's 13F filing for Q4 2014, filed 17 Feb 2015.